Background: Functional techniques like diffusion-weighted imaging (DWI) are gaining more and more importance in liver magnetic resonance imaging (MRI). Diffusion kurtosis imaging (DKI) is an advanced technique that might help to overcome current limitations of DWI. Purpose: To evaluate DKI for the differentiation of hepatic lesions in comparison to conventional DWI at 3 Tesla. Material and Methods: Fifty-six consecutive patients were examined using a routine abdominal MR protocol at 3 Tesla which included DWI with b-values of 50, 400, 800, and 1000 s/mm 2 . Apparent diffusion coefficient maps were calculated applying a standard mono-exponential fit, while a non-Gaussian kurtosis fit was used to obtain DKI maps. ADC as well as 
Introduction
Diffusion describes the random Brownian motion of gaseous or liquid molecules. Signal changes on diffusion-weighted imaging (DWI) represent alterations in the microscopic mobility of water in tissues. In a homogenous medium, diffusion is described as having Gaussian behavior. However, in general, the diffusion of water in living tissues is restricted by interactions with other molecules and cell membranes and is therefore thought to display non-Gaussian diffusion properties. The choice of b-values in conventional DWI influences the apparent diffusion coefficients (ADC) obtained. Diffusion kurtosis imaging (DKI) has been proposed as a novel imaging technique to help overcome this limitation. DKI as a diffusion model was introduced by Jensen in 2005 (1) to account for the non-Gaussian diffusion properties of water in complex structures. DKI enables acquisition of dimensionless measurements reflecting the degree of diffusion restriction (1) (2) (3) . Results obtained with DKI models may thus better reflect diffusion properties in tissue.
DKI has been investigated in the central nervous system to evaluate conditions such as malignancy, degenerative processes, and stroke (4-7), and has recently been applied to imaging of prostate cancer (8) and the ex vivo assessment of hepatocellular carcinoma (9, 10) . For prostate imaging, DKI showed a higher sensitivity in the differentiation of both normal from cancerous areas as well as low-from high-grade carcinomas (8) . In hepatocellular carcinoma, a non-Gaussian behavior of diffusion was found ex vivo, with Kurtosis corrected diffusion coefficients being statistically significantly higher than conventional ADC values (10) . In those applications, DKI protocols typically included additional ultrahigh b-values for DKI calculations. However, the number of b-values acquired in clinical protocols is typically limited to 3-5, especially as high b-value DWI requires averaging to receive sufficient signalto-noise ratio (SNR) on clinical magnetic resonance (MR) scanners. Particularly in severely ill patients, the necessary increase in examination time needed for additional b-value acquisition becomes the limiting factor for including DKI as described in ex vivo studies in clinical routine protocols. As shown for applications in the imaging of pancreatic lesions, DKI derived from clinical standard b-values can deliver additional information beyond calculations based on mono-exponential fit (11) . To date, no previous studies have investigated the feasibility of DKI for the differentiation of hepatic lesions in vivo. The aim of the study was to evaluate the diagnostic performance of clinical standard b-value based DKI in comparison to standard ADC for the differentiation of benign and malignant focal hepatic lesions.
Material and Methods Patients
Following Institutional Review Board approval, 56 consecutive patients (38 men; mean age, 57 years; age range, 21-86 years) were included in this retrospective study. Patients were referred for liver MRI for different indications including cancer staging, characterization of known focal lesions and follow-up examinations.
MR imaging
Magnetic resonance imaging (MRI) examination was performed according to our institutional standard operation procedure at a 3 Tesla whole-body MR scanner (Magnetom Skyra, Siemens Healthcare, Erlangen, Germany). Depending on the clinical indication for the study, an extracellular, non-specific (n ¼ 20 patients, gadoterate meglumine [Dotarem Õ , Guerbet, Roissy, France]) or a liver-specific (n ¼ 36, gadoxetic acid [Primovist Õ , Bayer Vital GmbH, Leverkusen, Germany]) contrast agent was used. The imaging protocol included T1-weighted (T1W) axial pre-contrast VIBE, T2-weighted (T2W) coronal and axial HASTE with and without fat suppression and postcontrast multi-phase T1W VIBE sequences. In patients receiving the extracellular contrast agent (ECCA group), DWI sequences were acquired prior to contrast injection. In patients receiving the hepatocyte-specific contrast agent (HSCA group), DWI was acquired starting 3 min post contrast injection. DWI was performed using a single-shot echo-planar sequence with b-values of 50, 400, 800, and 1000 s/mm 2 (12, 13) based on the four acquired b-values. A standard mono-exponential fit was used to calculate ADC, and a non-Gaussian kurtosis fit was used to calculate the DKI values K, a measure of excess kurtosis of diffusion, and D, a corrected diffusion coefficient accounting for this non-Gaussian behavior. To generate DKI maps, the following equation was fit pixel-wise to the image data (2):
where S(b) represents the images acquired with different b-values (diffusion weightings) and S(b 0 ) is the signal of the unweighted image.
Image analysis
Image analysis was performed by two radiologists with eight and four years of experience in abdominal MRI, respectively. The readers had access to all available image data to identify focal liver lesions. For every lesion that was identified, a region of interest (ROI) approach was used to further analyze ADC and DKI maps. ROIs were placed in the lesions and directly copied from ADC to DKI maps. Care was taken to exclude vessels and bile ducts when placing the ROIs.
To reduce the influence of signal noise while minimizing partial volume effects, ROIs were placed on three consecutive slices including the lesion center. Mean ADC, mean corrected diffusion (D), and mean kurtosis value (K) were calculated. For final lesion characterization and classification, all available clinical information (including histology after biopsy or resection) and/or previous and follow-up examinations was taken into account. Lesions with homogenous low signal on T1W and very high signal on T2W sequences without changes in T1 signal intensity after injection of the contrast agent and without septations or wall irregularities were classified as cysts.
Statistical analysis
Statistical analyses were performed using SAS 9.4 (SAS Institute, Cary, NC, USA) and StatXact (Cytel Studio, Cambridge, MA, USA). DWI and DKI parameters were compared using t-tests. In case of multiple testing, Bonferroni correction was performed. Twofold unbalanced ANOVA for the lesion groups and contrast media was performed. A classification of malignancy in terms of ADC and diffusion values are given and compared to the histologic findings. Based on that a sensitivity analysis and a ROC curve analysis is presented. All values are reported as mean AE standard deviation. A P value <0.05 was considered statistically significant.
Results
The Kurtosis fitting model as well as the standard mono-exponential fit could be applied and DKI and ADC maps were generated successfully in all cases (Fig. 1 ). In the ECCA group, a total of 23 focal liver lesions was identified, consisting of nine cysts, eight hepatocellular carcinomas (HCC), and six hepatic hemangiomas (HH). Forty-five lesions in total were found in the HSCA group, consisting of four hepatic adenomas (HA), three focal nodular hyperplasias (FNH), 12 HHs, 17 HCCs, and nine cysts. For HCCs, all lesions except for two were confirmed by histology after biopsy (n ¼ 22) or resection (n ¼ 1). In two cases, histology was not available; however, both patients underwent additional computed tomography (CT) or contrastenhanced sonography, in which the lesions were also found to be highly suspicious of HCC. For HH, two lesions were confirmed by histology after resection; mean follow-up time of the remaining HH was 14 months. One FNH was confirmed by histology after resection; mean follow-up time for remaining FNH was 48 months. Mean follow-up for HA was 32 months. In total, 68 hepatic lesions were included, of which 25 were malignant (HCC) and 43 benign (HH, HA, FNH, and cysts).
ADC analysis
In 2 ) was lower than HH, but higher than HCC.
In the comparison of mean ADC values in both contrast agent groups, HCC showed statistically significant differences in comparison to cysts (P < 0.0001), HH (P < 0.0001), and HA (P ¼ 0.01), while no statistically significant difference was found in the comparison to FNH (P ¼ 0.16). À3 mm/s 2 in the HSCA group). In the comparison of mean D values in both contrast agent groups, HCC showed statistically significant differences in comparison to cysts (P < 0.0001), HH (P < 0.0001), and HA (P ¼ 0.04), while no statistically significant difference was found in the comparison to FNH (P ¼ 0.25). The variance between the lesion groups and the treatment factors was statistically significant (P < 0.0001 and P ¼ 0.02, respectively). A leading opposite influence by HCC lesions compared to HH and cysts and an influence of the contrast process used was found (group effects for HCC ¼ À1. 16 value was assumed. Five classes of malignancies were grouped around these values (Table 3) . Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for ADC were 85.7%, 97.5%, 96.0%, and 90.7%, respectively. For D, sensitivity, specificity, PPV, and NPV were 75.0%, 90.0%, 84.0%, and 83.7%, respectively. In the ROC analysis, the area under curve (AUC) was 0.9149 for ADC and 0.9847 for D (Fig. 3) .
Discussion
Our results demonstrate that D, the corrected diffusion coefficient, derived from a standard clinical DWI protocol allows a differentiation of focal benign and malignant liver lesions. D values derived from a clinical DWI protocol including b-values up to 1000 s/mm 2 showed a separation effect that was comparable to the conventional ADC values. The potential value of DKI for focal liver lesion differentiation is underlined by a recent study, in which DKI allowed for an ex vivo differentiation between non-, partially and completely necrotic hepatocellular carcinomas (10) . In vivo, however, studies specifically investigating the value of DKI for the differentiation of focal liver lesions have not yet been performed. In contrast to ex vivo liver imaging, in vivo MRI is influenced by respiratory motion artifacts, pulsation artifacts of the liver vessels, and particularly a limited scan time. While Rosenkrantz et al. (14) suggest higher b-values than 1000 s/mm 2 , the practicability of such an approach is limited by low SNR at clinical scanners (15) . Especially for critically ill patients, the additional scanning time needed particularly for the acquisition of ultra-high b-value DWI will often not be tolerated, resulting in premature termination of the examination or reduction of image quality because of motion artifacts.
Thus, the focus of this work was the evaluation of DKI analysis based on a clinical feasible and routinely used protocol without any additional acquisition time and utilizing an in-house built software plug-in in a ready-to-use approach.
While conventional DWI has been proven to be a useful tool for the evaluation of abdominal lesions, its limitations are well-known including non-standardization of protocols, subsequent variability in reported ADC values, and ADC value dependence on field strength, vendor, and variations in calculation techniques (mono versus bi-exponential) (16) . A recent study compared DKI and conventional DWI in the assessment of therapeutic effects in HCC treatment (9) . In this study, DKI was found to provide a higher diagnostic performance in the detection of viable HCCs after therapy than conventional DWI. The authors postulate that DKI might be less influenced by parenchymal micro-perfusion. Thus, DKI might better reveal changes in diffusion restriction, while ADC differences might be attributed to changes in micro-perfusion rather than changes in true diffusion restriction. This is also supported by studies examining intravoxel coherent motion effects in pancreatic DWI (17, 18) . Additionally, DKI was found to be less influenced by the degree of liver fibrosis (9) . Thus, cutoff DKI values for different focal lesion types should be applicable independently of accompanying diffuse liver parenchyma alterations. In their study (9), Goshima et al. found completely necrotic HCC lesions to feature higher ADC but lower mean kurtosis values than viable HCC tissue. This finding implies that several effects-like micro-perfusion-contribute to ADC values, while DKI more likely reveals the differences in true structural complexity. Thus, DKI might also be beneficial in the differentiation and classification of focal liver lesions based on their structural complexity. Even though recent studies showed that DWI can be acquired before or after contrast media injection with no relevant effect on quantitative ADC values (19) , we chose to analyze both groups separately. This was done as the influence of contrast agent administration on DKI values in this setting is not known. Additionally, an influence of the contrast agent was found for both ADC and D for all lesion types in the ANOVA analysis. Thus, before using DKI-based quantitative information in clinical decision-making, further studies on the influence of contrast media administration on those quantitative approaches are necessary There are limitations of the present study. The relatively small sample size and the lack of a histological reference for most benign lesions included in our study limit the generalizability of the results herein. Although the accuracy of DKI and DWI was not compared to a histological gold standard in those cases, long-term follow-up was available. Further studies with pathologic correlation as well as DKI imaging with b-values higher than 1000 s/mm 2 are necessary to confirm these initial results and to further investigate the usefulness of DKI for the differentiation of focal liver lesions and its value in comparison to other functional imaging techniques (20) .
In conclusion, the application of DKI using a clinical abdominal DWI sequence at 3 Tesla is feasible. Even though the technique allows for accurate discrimination between malignant and benign liver lesions, its additional value compared to conventional ADC values is limited. Further studies including higher b-value DWI will be needed to show the potential benefit of DKI in the differentiation of focal hepatic lesions.
